Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes in the Future

International standardization and coordination of the nomenclature of variants of hepatitis C virus (HCV) is increasingly needed as more is discovered about the scale of HCV-related liver disease and important biological and antigenic differences that exist between variants.

A group of scientists expert in the field of HCV genetic variability, and those involved in development of HCV sequence databases, the Hepatitis Virus Database (Japan), euHCVdb (France), and Los Alamos (United States), met to re-examine the status of HCV genotype nomenclature, resolve conflicting genotype or subtype names among described variants of HCV, and draw up revised criteria for the assignment of new genotypes as they are discovered in the future.

A comprehensive listing of all currently classified variants of HCV incorporates a number of agreed genotype and subtype name reassignments to create consistency in nomenclature.

The paper also contains consensus proposals for the classification of new variants into genotypes and subtypes, which recognizes and incorporates new knowledge of HCV genetic diversity and epidemiology.

A proposal was made that HCV variants be classified into 6 genotypes (representing the 6 genetic groups defined by phylogenetic analysis).

Subtype name assignment will be either confirmed or provisional, depending on the availability of complete or partial nucleotide sequence data, or remain unassigned where fewer than 3 examples of a new subtype have been described.

The authors conclude, “These proposals provide the framework by which the HCV databases store and provide access to data on HCV, which will internationally coordinate the assignment of new genotypes and subtypes in the future.”

Table 1. Confirmed HCV Genotypes/Subtypes

Table 2. Listing of HCV Variants With Proposed Changes
  
            in Genotype Nomenclature

Table 3. Provisionally Assigned HCV Subtypes

09/30/05

Reference
P Simmonds and others. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4): 962-973.

Table 1. Confirmed HCV Genotypes/Subtypes


Genotype*

Locus/Isolate(s)

Accession number(s)

Reference(s)


Genotype 1

     

   1a

HPCPLYPRE, HPCCGAA

M62321, M67463

[67],[68]

   1b

HPCJCG, HPCHUMR

D90208, M58335

[69],[70]

   1c

HPCCGS, AY051292

D14853, AY051292

[71]

Genotype 2

     

   2a

HPCPOLP, JFH-1

D00944, AB047639

[72],[73]

   2b

HPCJ8G, JPUT971017

D10988, AB030907

[9],[74]

   2c

BEBE1

D50409

[75]

   2k

VAT96

AB031663

[58]

Genotype 3

     

   3a

HPCEGS, HPCK3A

D17763, D28917

[76],[77]

   3b

HPCFG

D49374

[78]

   3k

HPCJK049E1

D63821

[59]

Genotype 4

     

   4a

HCV4APOLY

Y11604

[79]

Genotype 5

     

   5a

EUH1480, SA13

Y13184, AF064490

[80],[81]

Genotype 6

     

   6a

HCV12083, 6a33

Y12083, AY858526

[82]

   6b

Th580

D84262

[83]

   6d

VN235

D84263

[83]

   6g

HPCJK046E2

D63822

[59]

   6h

VN004

D84265

[83]

   6k

VN405

D84264

[83]


   NOTE. Tables 1, 2, and 3 were compiled by a working group of Donald Murphy, Erwin Sablon, and Phillipe Halfon.
  * Consensus proposed genotype/subtype names. For instances in which multiple sequences of a HCV genotype are available, two sequences have been listed, prioritized by (1) publication date, or (2) submission date when unpublished.
   Locus (or isolate name, if locus is the same as the accession number).
   Sequence obtained from acute phase plasma of a chimpanzee experimentally infected with (human-derived) isolate SA13.
Simmonds et al. Hepatology 42(4). October 2005.

          

 

Table 2. Listing of HCV Variants With Proposed Changes in Genotype Nomenclature


Proposed Designation*

Published Designation

Status

Isolate

Region Sequenced§

Reference(s)


Genotype 2

         

   2k

2j

C

RU169

NS5B (D86532), 3UTR (D86532)

[83]

   2j

2l

P

BA047

NS5B (D86530), 3UTR (D86530)

[83]

   2n

2e

P

NL50

C/E1 (L39309), NS5B (L44602)

[84]

   2o

4f/2f

P

FR4

C/E1 (L38333), NS5B (L38373)

[84]

   2p

2f

P

NL33

C/E1, (L39300), BS5B (L44601)

[84]

   2q

2k

P

BA045

NS5B (D86529), 3UTR (D86529)

[83]

Genotype 3

         

   3k

10a

C

HPCJK049E1

Complete genome (D63821)

[59]

Genotype 4

         

   4r

4a

P

Z4

C/E1 (U10236/L16652)

[12],[64]

     

FrSSD120

C/E1 (AJ401097), NS5B (AJ291282)

[93]

   4n

4 alfa

P

1359

C/E1 (AF271874)

[65]

   4o

4 beta

P

2153

C/E1 (AF271882), NS5B (AF271815)

[65]

Genotype 6

         

   6c

7d

P

Th846

C/E1 (D37843), NS5B (D37857)

[35]

   6d

7b

C

VN235

Complete genome (D84263)

[83]

   6e

7a

P

VN540

C/E1 (D88474), NS5B (D87361)

[34]

   6f

7e

P

BB7

NS5B (D28541)

[96]

   6f

7c

P

Th271

C/E1 (D37844), NS5B (D37858)

[35]

   6g

11a

C

HPCJK046E

Complete genome (D63822)

[59]

   6h

9a

C

VN004

Complete genome (D84265)

[83]

   6i

9b

P

Th555

C/E1 (D37849), NS5B (D37863)

[35]

   6j

9c

P

Th553

C/E1 (D37848), NS5B (D37862)

[35]

   6k

8b

C

VN405

Complete genome (D84264)

[34]

   6l

8a

P

VN507

C/E1 (D88470), NS5B (D87357)

[34]


  * Proposed new name based on revised criteria for genotype designations.
   Classification status; C: Confirmed; P: Provisional.
   Example of isolates referred to in associated publications (last column).
  § Regions sequenced (accession numbers in parentheses), prioritized for (1) complete genome; (2) Core/E1 and NS5B regions; (3) other regions where core/E1 and NS5B regions are not both available.
 
Simmonds et al. Hepatology 42(4). October 2005

 

 

Table 3. Provisionally Assigned HCV Subtypes


 

Isolate

Accession Number(s)*

Reference(s)

Core/E1

NS5B


Genotype 1

       

   1d

HC1-N15, HC1-N16

L39299, L39302

L38377, L38372

[84]

   1e

CAM1078, QC248

L38349(C), AY894555

L38361, AY894553

[62],[84]

   1f

FR2

L38350

L38371

[84]

   1g

2152, 1382

AF271822, AF271820

AF271798, AF271797

[65]

   1h

98CM1521, QC94

AY256790(C), AY434131

AY257087, AY434132

[32],[62]

   1i

FR16, QC77

n.a., AY434119

L48495, AY434120

[62],[85]

   1j

QC2, QC89

AY434158, AY434128

AY434106, AY434129

[62]

   1k

QC68, QC82

AY434112, AY434122

AY434113, AY434123

[62]

   1l

98CM1383, 98CM1427

AY256789(C), AY256792(C)

AY257083, AY257091

[32]

Genotype 2

       

   2d

NE92, BN177

L39294, n.a.

L29634, AF037244

[66],[86]

   2e

JK020, JK025

D49745, D49746

D49760, D49761

[59]

   2f

JK081, JK139

D49754, D49757

D49769, D49777

[59]

   2g

MED017

n.a.

X93323

[26]

   2h

MED007

n.a.

X93327

[26]

   2i

FR13, HN4

n.a., X76411/X76415

L48492, L48499

[87],[88]

   2j

BA047, QC106

n.a., AY894528

D86530, AY894526

[62],[83]

   2l

FR15